OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulating tumor suppressor genes: post-translational modifications
Ling Chen, Shuang Liu, Yongguang Tao
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 324

Showing 1-25 of 324 citing articles:

p53 signaling in cancer progression and therapy
Hany E. Marei, Asmaa Althani, Nahla Afifi, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 368

Targeting p53 pathways: mechanisms, structures and advances in therapy
Haolan Wang, Ming Guo, Hudie Wei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 365

Deubiquitinase-targeting chimeras for targeted protein stabilization
Nathaniel J. Henning, Lydia Boike, Jessica N. Spradlin, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 4, pp. 412-421
Open Access | Times Cited: 209

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Xiaohua Chen, Taotao Zhang, Wei Su, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 189

Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery
Yang Woo Kwon, Han-Seul Jo, Sungwon Bae, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 180

Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response
Nathan A. Snyder, Gustavo M. Silva
Journal of Biological Chemistry (2021) Vol. 297, Iss. 3, pp. 101077-101077
Open Access | Times Cited: 171

Posttranslational Modifications in Ferroptosis
Xiang Wei, Xin Yi, Xue‐Hai Zhu, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 144

JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 130

Pathological implication of protein post-translational modifications in cancer
Sheng Pan, Ru Chen
Molecular Aspects of Medicine (2022) Vol. 86, pp. 101097-101097
Open Access | Times Cited: 127

Targeted therapy for head and neck cancer: signaling pathways and clinical studies
Qingfang Li, Yan Tie, Aqu Alu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 123

Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis
Yinan Xiao, Meiyu Bi, Hongyan Guo, et al.
EBioMedicine (2022) Vol. 79, pp. 104001-104001
Open Access | Times Cited: 115

A Systematic Review of Biosynthesized Metallic Nanoparticles as a Promising Anti-Cancer-Strategy
Anisa Andleeb, Aneeta Andleeb, Salman Asghar, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2818-2818
Open Access | Times Cited: 114

Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
Chen Shen, Xin Jiang, Mei Li, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 74

The landscape of T cell antigens for cancer immunotherapy
Aviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Nature Cancer (2023) Vol. 4, Iss. 7, pp. 937-954
Closed Access | Times Cited: 60

Liposomes for the Treatment of Brain Cancer—A Review
R. Raju, Waad H. Abuwatfa, William G. Pitt, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1056-1056
Open Access | Times Cited: 41

Genetic expression in cancer research: Challenges and complexity
Hengrui Liu, Zheng Guo, Panpan Wang
Gene Reports (2024), pp. 102042-102042
Closed Access | Times Cited: 24

Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases
Bowen Yang, Yumeng Lin, Yibo Huang, et al.
Redox Biology (2024) Vol. 70, pp. 103032-103032
Open Access | Times Cited: 18

Oncogenes and tumor suppressor genes: functions and roles in cancers
Tikam Chand Dakal, Bhanupriya Dhabhai, Anuja Pant, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 17

AMPKα1-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma
Zhangjie Wang, Yang Wang, Na Shen, et al.
Cancer Letters (2024) Vol. 584, pp. 216619-216619
Closed Access | Times Cited: 15

The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Qinglong Ma, Wenyang Zhang, Kongming Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3

PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
Nicola Fusco, Elham Sajjadi, Konstantinos Venetis, et al.
Genes (2020) Vol. 11, Iss. 7, pp. 719-719
Open Access | Times Cited: 114

Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
Lingyue Gao, Zhuo‐Xun Wu, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2021) Vol. 57, pp. 100770-100770
Closed Access | Times Cited: 96

Applications of graphene-based electrochemical and optical biosensors in early detection of cancer biomarkers
Fareeha Arshad, Faisal Nabi, Sana Iqbal, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 212, pp. 112356-112356
Closed Access | Times Cited: 60

Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment
Alireza Mafi, Atefe Rahmati, Zahra Babaei Aghdam, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 44

Page 1 - Next Page

Scroll to top